Metronidazole and ciprofloxacin differentially affect chronic unpredictable mild stress-induced changes in the colon,

Chen Meng1,2, Chen Dong3, Hong Liu4,5,6

  • 1School of Biological Science and Medical Engineering, Institute of Environmental Biology and Life Support Technology, Beihang University, Beijing, 100083, China.

Insights

Chronic unpredictable mild stress (CUMS) combined with antibiotics like metronidazole and ciprofloxacin alters gut microbiota composition and diversity in rats. Antibiotic exposure differentially impacts gut bacteria, affecting richness and abundance in various segments.

Area of Science:

  • Microbiology
  • Pharmacology
  • Physiology

Background:

  • Gut microbiota homeostasis is disrupted by unpredictable stress and antibiotic exposure.
  • The combined effects of stress and antibiotics on gut microbiota remain poorly understood.

Purpose of the Study:

  • To investigate the impact of combined metronidazole and ciprofloxacin antibiotic treatment on gut microbiota dysbiosis induced by chronic unpredictable mild stress (CUMS) in rats.
  • To analyze changes in gut microbiota composition, diversity, and abundance in different segments (colon, cecum, ileum) following stress and antibiotic exposure.

Main Methods:

  • Rats were subjected to CUMS to induce stress.
  • Antibiotic treatment (metronidazole and ciprofloxacin) was administered post-CUMS.
  • Organ coefficients (thymus, liver, spleen) were measured.
  • 16S rRNA gene sequencing was used to analyze gut microbiota in the colon, cecum, and ileum.

Main Results:

  • Antibiotics reduced CUMS-induced increases in spleen coefficients.
  • Short-term antibiotic exposure increased cecum and ileum microbiota richness and ileum diversity.
  • Long-term antibiotic exposure decreased colon microbiota diversity but increased ileum richness.
  • Verrucomicrobia became the most abundant bacteria in all gut segments after long-term antibiotic exposure.
  • Antibiotic exposure increased Lactobacillus and Akkermansia abundance in specific gut segments.

Conclusions:

  • Metronidazole and ciprofloxacin differentially modulate stress-induced gut microbiota alterations.
  • Antibiotic treatment impacts gut microbiota richness, diversity, and specific bacterial abundances in a segment-dependent manner.
  • The study highlights the complex interplay between stress, antibiotics, and the gut microbiome.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
233
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
538
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
378
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
230